BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24715844)

  • 1. Pure mucinous breast carcinoma: a favorable subtype.
    Yang M; Li X; Chun-Hong P; Lin-Ping H
    Breast Care (Basel); 2013 Mar; 8(1):56-9. PubMed ID: 24715844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics of mucinous carcinoma of the breast.
    Hanagiri T; Ono K; Baba T; So T; Yamasaki M; Nagata Y; Uramoto H; Takenoyama M; Yasumoto K
    Int Surg; 2010; 95(2):126-9. PubMed ID: 20718318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
    Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
    Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
    Lei L; Yu X; Chen B; Chen Z; Wang X
    PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes.
    Emiroglu S; Tukenmez M; Karakus S; Karanlik H; Onder S; Ozmen V; Cabioglu N; Ozkurt E; Yilmaz R; Muslumanoglu M
    Eur J Breast Health; 2022 Oct; 18(4):353-359. PubMed ID: 36248750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure mucinous carcinoma of the breast: a single center experience.
    Dogan E; Aksoy S; Dizdar O; Arslan C; Dede DS; Ozisik Y; Altundag K
    J BUON; 2011; 16(3):565-7. PubMed ID: 22006768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
    Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
    Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: review of patients over an 8-year period.
    Ng WK
    Cancer; 2002 Oct; 96(5):280-8. PubMed ID: 12378595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous breast carcinoma a rare entity to be known: clinico-pathological study of 48 cases.
    El Amine El Hadj O; Ayadi M; Goucha A; Ben Hassouna J; Rahal K; El May A; Gamoudi A
    Tunis Med; 2016; 94(8-9):525-530. PubMed ID: 28603824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
    Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucinous breast carcinoma: a large contemporary series.
    Barkley CR; Ligibel JA; Wong JS; Lipsitz S; Smith BL; Golshan M
    Am J Surg; 2008 Oct; 196(4):549-51. PubMed ID: 18809061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features and risk factors for recurrence in mucinous breast cancer].
    Lei L; Chen ZZ; Zheng YB; Chen B; Wang X; Wang XJ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):274-279. PubMed ID: 28550667
    [No Abstract]   [Full Text] [Related]  

  • 15. Male breast cancer: a clinicopathologic study of 42 patients in eastern India.
    Shah S; Bhattacharyya S; Gupta A; Ghosh A; Basak S
    Indian J Surg Oncol; 2012 Sep; 3(3):245-9. PubMed ID: 23997516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of a Micropapillary Pattern in Pure Mucinous Carcinoma of the Breast: Comparative Analysis with Micropapillary Carcinoma.
    Kim HJ; Park K; Kim JY; Kang G; Gwak G; Park I
    J Pathol Transl Med; 2017 Jul; 51(4):403-409. PubMed ID: 28597867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.
    Turashvili G; Brogi E; Morrow M; Hudis C; Dickler M; Norton L; Wen HY
    Breast Cancer Res Treat; 2017 Aug; 165(1):65-76. PubMed ID: 28577081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous carcinoma of the breast: a pathologic study of 82 cases.
    André S; Cunha F; Bernardo M; Meneses e Sousa J; Cortez F; Soares J
    J Surg Oncol; 1995 Mar; 58(3):162-7. PubMed ID: 7898111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
    Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
    Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.